Significant ototoxicity limits the use of aminoglycoside (AG) antibiotics. Several mechanisms may contribute to the death of both auditory and vestibular hair cells. In this study the effects of gentamicin and neomycin on K+ currents in mature and early postnatal type I vestibular hair cells (HCI) were tested directly. The whole-cell patch clamp technique was used to assess the effects of AG and KCNQ channel modulators on K+ currents (IK) in HCI acutely isolated from gerbil semicircular canals. Extracellular neomycin (1 mM) rapidly reduced peak outward IK by 16 ± 4% (n = 9) in mature HCI (postnatal days, P, 25-66). Gentamicin (5 mM) reduced outward IK by 16 ± 3% (n = 8). A similar reduction in outward current was seen in immature HCI (P5-9) that lacked the low-voltage-activated component of IK observed in mature cells. Intracellular application of gentamicin and neomycin also reduced IK in mature HCI. Modulators of KCNQ channels were used to probe KCNQ channel involvement. The selective KCNQ antagonist XE991 did not reduce IK and the neomycin-induced reduction in IK was not reversed by the KCNQ agonist flupirtine. Application of intracellular poly-D-lysine to sequester PIP2 did not reduce IK. Application of the K+ channel blocker 4-aminopyridine (4-AP) strongly reduced IK, and extracellular AG in the presence of 4-AP gave no further inhibition of IK. In summary, AG significantly reduce the 4-AP-sensitive IK in early postnatal and mature HCI. K+ current inhibition differs from that seen in outer hair cells, since it does not appear to involve PIP2 sequestration or KCNQ channels.

Keywords:
Semicircular canals, Crista, KCNQ channels, Aminoglycoside toxicity
1.
Alharazneh A, Luk L, Huth M, Monfared A, Steyger PS, Cheng AG, Ricci AJ: Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity. PLoS One 2011;6:e22347.
2.
Bao H, Wong WH, Goldberg JM, Eatock RA: Voltage-gated calcium channel currents in type I and type II hair cells isolated from the rat crista. J Neurophysiol 2003;90:155-164.
3.
Blakley BW: Update on intratympanic gentamicin for Ménière's disease. Laryngoscope 2000;110:236-240.
4.
Blanchet C, Erostegui C, Sugasawa M, Dulon D: Gentamicin blocks ACh-evoked K+ current in guinea-pig outer hair cells by impairing Ca2+ entry at the cholinergic receptor. J Physiol 2000;525(pt 3):641-654.
5.
Chen JM, Kakigi A, Hirakawa H, Mount RJ, Harrison RV: Middle ear instillation of gentamicin and streptomycin in chinchillas: morphologic appraisal of selective ototoxicity. J Otolaryngol 1999;28:121-128.
6.
Chen JWY, Eatock RA: Major potassium conductance in type I hair cells from rat semicircular canals: characterization and modulation by nitric oxide. J Neurophysiol 2000;84:139-151.
7.
Cunningham LL, Cheng AG, Rubel EW: Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurophysiol 2002;22:8532-8540.
8.
Dehne N, Rauen U, de Groot H, Lautermann J: Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res 2002;169:47-55.
9.
Dhawan R, Mann SE, Meredith FL, Rennie KJ: K+ currents in isolated vestibular afferent calyx terminals. J Assoc Res Otolaryngol 2010;11:463-476.
10.
Dulon D, Sugasawa M, Blanchet C, Erostegui C: Direct measurements of Ca2+-activated K+ currents in inner hair cells of the guinea-pig cochlea using photolabile Ca2+ chelators. Pflügers Arch 1995;430:365-373.
11.
Eatock RA, Hurley KM: Functional development of hair cells. Curr Top Dev Biol 2003;57:389-448.
12.
Forge A, Schacht J: Aminoglycoside antibiotics. Audiol Neurotol 2000;5:3-22.
13.
Géléoc GSG, Risner JR, Holt JR: Developmental acquisition of voltage-dependent conductances and sensory signaling in hair cells of the embryonic mouse inner ear. J Neurosci 2004;24:1148-1159.
14.
Hashino E, Shero M: Endocytosis of aminoglycoside antibiotics in sensory hair cells. Brain Res 1995;704:135-140.
15.
Hiel H, Schamel A, Erre JP, Hayashida T, Dulon D, Aran JM: Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acid. Hear Res 1992;57:157-165.
16.
Hirvonen TP, Minor LB, Hullar TE, Carey JP: Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla. J Neurophysiol 2005;96:643-655.
17.
Holt JR, Stauffer EA, Abraham D, Géléoc GSG: Dominant-negative inhibition of M-like potassium conductances in hair cells of the mouse inner ear. J Neurosci 2007;27:8940-8951.
18.
Hurley KM, Gaboyard S, Zhong M, Price SD, Wooltorton JRA, Lysakowski A, Eatock RA: M-like K+ currents in type I hair cells and calyx afferent endings of the developing rat utricle. J Neurosci 2006;40:10253-10269.
19.
Jiang H, Sha SH, Schacht J: Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo. J Neurochem 2006;99:269-276.
20.
Kharkovets T, Hardelin JP, Safieddine S, Schweizer M, El-Amraoui A, Petit C, Jentsch TJ: KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci USA 2000;97:4333-4338.
21.
Kroese AB, Das A, Hudspeth AJ: Blockage of the transduction channels of hair cells in the bullfrog's sacculus by aminoglycoside antibiotics. Hear Res 1989;37:203-217.
22.
Kros CJ, Rüsch A, Richardson GP: Mechano-electrical transducer currents in hair cells of the cultured neonatal mouse cochlea. Proc Biol Sci 1992;249:185-193.
23.
Lee JE, Nakagawa T, Kim TS, Iguchi F, Endo T, Kita T, Murai N, Naito Y, Lee SH, Ito J: Signaling pathway for apoptosis of vestibular hair cells of mice due to aminoglycosides. Acta Otolaryngol Suppl 2004;551:69-74.
24.
Leitner MG, Halaszovich CR, Oliver D: Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate. Mol Pharmacol 2011;79:51-60.
25.
Li G, Meredith FL, Rennie KJ: Development of K+ and Na+ conductances in rodent postnatal semicircular canal type I hair cells. Am J Physiol Regul Integr Comp Physiol 2010;298:R351-R358.
26.
Lin X, Hume RI, Nuttall AL: Voltage-dependent block by neomycin of the ATP-induced whole cell current of guinea-pig outer hair cells. J Neurophysiol 1993;70:1593-1605.
27.
Lindeman HH: Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol 1969;67:177-189.
28.
Liu SQ, Kaczmarek LK: Aminoglycosides block the Kv3.1 potassium channel and reduce the ability of inferior colliculus neurons to fire at high frequencies. J Neurobiol 2005;62:439-452.
29.
Lopez I, Honrubia V, Lee SC, Schoeman G, Beykirch K: Quantification of the process of hair cell loss and recovery in the chinchilla crista ampullaris after gentamicin treatment. Int J Dev Neurosci 1997;15:447-461.
30.
Lyford-Pike S, Vogelheim C, Chu E, della Santina CC, Carey JP: Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. JARO 2007;8:497-508.
31.
Lysakowski A, Gaboyard-Niay S, Calin-Jageman I, Chatlani S, Price SD, Eatock RA: Molecular microdomains in a sensory terminal, the vestibular calyx ending. J Neurosci 2011;31:10101-10114.
32.
Mammano F, Kros CJ, Ashmore JF: Patch clamped responses from outer hair cells in the intact adult organ of Corti. Pflügers Arch 1995;430:745-750.
33.
Marcotti W, van Netten SM, Kros CJ: The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. J Physiol 2005;567:505-521.
34.
Miceli F, Soldovieri MV, Martire M, Taglialatela M: Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 2008;8:65-74.
35.
Ohmori H: Mechano-electrical transduction currents in isolated vestibular hair cells of the chick. J Physiol 1985;359:189-217.
36.
Rennie KJ, Correia MJ: Potassium currents in mammalian and avian isolated type I semicircular canal hair cells. J Neurophysiol 1994;71:317-329.
37.
Rennie KJ, Weng TX, Correia MJ: Effects of KCNQ channel blockers on K+ currents in vestibular hair cells. Am J Physiol Cell Physiol 2001;280:C473-C480.
38.
Ricci AJ, Rennie KJ, Cochran SL, Kevetter GA, Correia MJ: Vestibular type I and type II hair cells. 1. Morphological identification in the pigeon and gerbil. J Vestib Res 1997;7:393-406.
39.
Rüsch A, Eatock RA: A delayed rectifier conductance in type I hair cells of the mouse utricle. J Neurophysiol 1996;76:995-1004.
40.
Rüsch A, Lysakowski A, Eatock RA: Postnatal development of type I and type II hair cells in the mouse utricle: acquisition of voltage-gated conductances and differentiated morphology. J Neurosci 1998;18:7487-7501.
41.
Selimoğlu E, Kalkandelen S, Erdoğan F: Comparative vestibulotoxicity of different aminoglycosides in the Guinea pigs. Yonsei Med J 2003;44:517-522.
42.
Spitzmaul G, Tolosa L, Winkelman BH, Heidenreich M, Frens MA, Chabbert C, de Zeeuw CI, Jentsch TJ: Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models. J Biol Chem 2013;288:9334-9344.
43.
Straube A: Pharmacology of vertigo/nystagmus/oscillopsia. Curr Opin Neurol 2005;18:11-24.
44.
Suh BC, Inoue T, Meyer T, Hille B: Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. Science 2006;314:1454-1457.
45.
Wang X, Jia S, Currall B, Yang S, He DZ: Streptomycin and gentamicin have no immediate effect on outer hair cell electromotility. Hear Res 2007;234:52-58.
46.
Warchol ME: Cellular mechanisms of aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 2010;18:454-458.
47.
Ward KM, Rounthwaite FJ: Neomycin ototoxicity. Ann Otol Rhinol Laryngol 1978;87:211-215.
48.
Wong WH, Hurley KM, Eatock RA: Differences between the negatively activating potassium conductances of mammalian cochlear and vestibular hair cells. J Assoc Res Otolaryngol 2004;5:270-284.
49.
Wooltorton JRA, Gaboyard S, Hurley KM, Price SD, Garcia JL, Zhong M, Lysakowski A, Eatock RA: Developmental changes in two voltage-dependent sodium currents in utricular hair cells. J Neurophysiol 2007;97:1684-1704.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.